REQUEST A DEMO
Total
USD $0.00
Search more companies

Amicus Srb D.O.O. (Serbia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Amicus Srb D.O.O. Profile Updated: October 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Amicus Srb D.O.O. is a company based in Serbia, with its head office in Belgrade. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. There are currently 201 (2023) people employed by Amicus Srb D.O.O.. In 2023, the company reported a net sales revenue increase of 18.21%. Its total assets grew by 5.58% over the same period. Amicus Srb D.O.O.’s net profit margin decreased by 0.05% in 2023.

Headquarters
Milorada Jovanovica 9
Belgrade; Belgrade; Postal Code: www.amicuspharma.eu

Contact Details: Purchase the Amicus Srb D.O.O. report to view the information.

Website: http://CUBE_PROFILES_YU

Basic Information
Total Employees:
Purchase the Amicus Srb D.O.O. report to view the information.
Outstanding Shares:
Purchase the Amicus Srb D.O.O. report to view the information.
Registered Capital:
Purchase the Amicus Srb D.O.O. report to view the information.
Incorporation Date:
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Procurator
Purchase this report to view the information.
Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Amicus Srb D.O.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
18.21%
Total operating revenue
18.21%
Operating profit (EBIT)
2.36%
EBITDA
4.08%
Net Profit (Loss) for the Period
16.12%
Total assets
5.58%
Total equity
23.07%
Operating Profit Margin (ROS)
-0.47%
Net Profit Margin
-0.05%
Return on Equity (ROE)
-1.12%
Debt to Equity Ratio
-2.91%
Quick Ratio
-0%
Cash Ratio
0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?